HomeADIL • NASDAQ
add
Adial Pharmaceuticals Inc
Previous close
$1.90
Day range
$1.83 - $1.90
Year range
$1.54 - $30.25
Market cap
2.63M USD
Avg Volume
133.34K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 1.89M | -2.85% |
Net income | -2.00M | 3.60% |
Net profit margin | — | — |
Earnings per share | -11.48 | -206.13% |
EBITDA | -1.89M | 2.85% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 5.88M | 56.81% |
Total assets | 6.67M | 32.30% |
Total liabilities | 1.40M | 43.15% |
Total equity | 5.28M | — |
Shares outstanding | 1.43M | — |
Price to book | 0.40 | — |
Return on assets | -76.43% | — |
Return on capital | -96.37% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | -2.00M | 3.60% |
Cash from operations | -1.32M | 8.89% |
Cash from investing | 0.00 | — |
Cash from financing | 2.60M | — |
Net change in cash | 1.27M | 187.69% |
Free cash flow | -660.15K | 15.34% |
About
Founded
2010
Headquarters
Website
Employees
5
